metaEvidence - overview


			DCR
mML - L2 - all population metastatic/adv melanoma (mML) mML - 2nd line (L2) mML - L2 - all population
versus gp100
	ipilimumab alone vs. gp100	1	-
	ipilimumab plus gp100 vs. gp100	1	-
versus ipilimumab alone
	Ipilimumab (10 mg/kg) vs. ipilimumab alone	1	1.19 [0.86; 1.63], 1 RCT, I2=0% inconclusive result
	ipilimumab plus gp100 vs. ipilimumab alone	1	-
versus placebo plus SoC
	ipilimumab plus SoC vs. placebo plus SoC	1	1.15 [0.79; 1.68], 1 RCT, I2=0% inconclusive result
mML - L2 - BRAF mutant metastatic/adv melanoma (mML) mML - 2nd line (L2) mML - L2 - BRAF mutant